Immunocore Holdings plc (IMCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.75B |
| Enterprise Value | 1.72B |
| P/E Ratio | -51.16 |
| PEG Ratio | 0.63 |
| Price/Sales Ratio | 3.79 |
| Price/Book Ratio | 3.98 |
| Enterprise/Revenue | 3.62 |
| Enterprise/EBITDA | -908.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.07 |
| Operating Margin | -0.07 |
| Return On Assets | -0.03 |
| Return On Equity | -0.08 |
| Revenue | 400.02M |
| Revenue/Share | 8.33 |
| Gross Profit | 391.66M |
| EBITDA | 520,000 |
| Net Income | -35.51M |
| Diluted EPS | -0.71 |
| Total Cash | 901.3M |
| Total Cash/Share | 17.48 |
| Total Debt | 435.74M |
| Total Debt/Equity | 1.04 |
| Current Ratio | 4.62 |
| Book Value Per Share | 8.14 |
| 52-Week Change | -8.01 |
| 52-Week High | 40.72 |
| 52-Week Low | 27.5 |
| Moving Average 50 Days | 31.46 |
| Moving Average 200 Days | 31.63 |
| Average Volume | 457,770 |
| Shares Outstanding | 50.3M |
| % Held by Institutions | 102.22 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |